AGORA Cancer Research Center
AGORA was inspired by the vision that the integration of progress in cancer research into clinical practice can be accelerated by bringing together interdisciplinary research teams of clinicians, cancer biologists, immunologists, bio-informaticians and bio-engineers. Initiated by the ISREC Foundation in 2013, the AGORA building was opened in 2018. The functioning of this translational cancer research center reflects a partnership between the Lausanne University Hospital (CHUV), the University of Lausanne (UNIL), the Swiss Federal Institute of Technology of Lausanne (EPFL), the University Hospitals of Geneva (HUG) and the University of Geneva (UNIGE).
Latest news
Events
Save the Date – AGORA Platform Tour
Events
AGORA PRS Seminar | October 27th
Events
EPFL Latsis Symposium 2026 | October 29-30
Events
Oncology Grand Rounds, Post ESMO – Part One | October 30th
Events
15 th Faculty & Staff Annual Retreat, Swiss Cancer Center Leman | November 2nd and 3rd
Events
DOF Seminar, Prof. Renato Ostuni | November 25th
Events
Ludwig Distinguished Lecture, Prof. John Wherry | November 19th
Events
Swiss Myeloid League (SMyLe) monthly Seminar series | October 15th
Latest publications
Strategies to develop therapeutic cancer vaccines for pancreatic cancer.
Coppi MM, Graciotti M, Digklia A, Kandalaft LE
The lancet. Gastroenterology & hepatology – 2026 Oct 14
Challenges in the use of the European Society for Radiotherapy and Oncology-European Organisation for Research and Treatment of Cancer oligometastatic disease classification system in ovarian cancer.
Macchia G, Morganti AG, Taylor A, (…), Herrera FG, Jereczek-Fossa BA, Guckenberger M
The Lancet. Oncology – 2026 Sep 28
Divergent medulloblastoma chromatin states disclose KDM2B as a selective dependency.
Tao R, Erkek-Ozhan S, Xu B, (…), Peng JC, Pfister SM, Northcott PA
Nature genetics – 2026 Sep 24
Revealing therapeutic single-cell transcriptomic signatures using a simple classifier.
Ma X, Seah YFS, Gfeller D, Merten CA
Cell reports methods – 2026 Sep 18
Dendritic cells as programmable platforms for cancer immunotherapy.
Liu Y, Marcandalli E, Liu Y, (…), Bayerl F, Pittet MJ, De Palma M
Trends in immunology – 2026 Sep 16
